Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reynolds

Showing results (41-50 of 1,272) with videos related to

Pageof 128
Sort By:
Expert Opinion on Investigational Drugs|July 1, 1997
Schizophrenia - advances in drug therapyG P Reynolds
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1994
Antipsychotic drug mechanisms and neurotransmitter systems in schizophreniaG P Reynolds
Physical Therapy|December 22, 2025
40 Years of PTJ: The Lure of Blank Pages and Blue ScreensJan P Reynolds
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewGavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|July 14, 2021
High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?Gavin P Reynolds
Journal of Animal Science|January 1, 1986
Utero-ovarian interactions during early pregnancy: role of conceptus-induced vasodilationL P Reynolds
Journal of Psychopharmacology (Oxford, England)|August 20, 2025
The pharmacology underlying the unique antipsychotic efficacy of clozapineGavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|April 3, 2026
Antipsychotic action and symptom specificity - down the bioinformatic rabbit holeGavin P Reynolds
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1989
Beyond the dopamine hypothesis. The neurochemical pathology of schizophreniaG P Reynolds
The International Journal of Neuropsychopharmacology|July 2, 2024
Understanding the Therapeutic Action of Antipsychotics: Not yet Beyond Striatal Dopamine? A Comment on Direktor et al. (2024)Gavin P Reynolds
Pageof 128

Showing results (41-50 of 1,272) with videos related to

Sort By:
Pageof 128
Expert Opinion on Investigational Drugs|July 1, 1997
Schizophrenia - advances in drug therapyG P Reynolds
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1994
Antipsychotic drug mechanisms and neurotransmitter systems in schizophreniaG P Reynolds
Physical Therapy|December 22, 2025
40 Years of PTJ: The Lure of Blank Pages and Blue ScreensJan P Reynolds
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewGavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|July 14, 2021
High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?Gavin P Reynolds
Journal of Animal Science|January 1, 1986
Utero-ovarian interactions during early pregnancy: role of conceptus-induced vasodilationL P Reynolds
Journal of Psychopharmacology (Oxford, England)|August 20, 2025
The pharmacology underlying the unique antipsychotic efficacy of clozapineGavin P Reynolds
Journal of Psychopharmacology (Oxford, England)|April 3, 2026
Antipsychotic action and symptom specificity - down the bioinformatic rabbit holeGavin P Reynolds
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1989
Beyond the dopamine hypothesis. The neurochemical pathology of schizophreniaG P Reynolds
The International Journal of Neuropsychopharmacology|July 2, 2024
Understanding the Therapeutic Action of Antipsychotics: Not yet Beyond Striatal Dopamine? A Comment on Direktor et al. (2024)Gavin P Reynolds
Pageof 128